## Note
nid: 1504653071585
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_2::Zanki_Step_2, #AK_Step2_v11::!Shelf::#Cards_AnKing_Did::6im, #AK_Step2_v11::!Shelf::IM::no_dupes, #AK_Step2_v11::!Shelf::IM::no_dupes::only_step2, #AK_Step2_v11::#OME_banner::Clinical::06_Infectious_Disease, #AK_Step2_v11::#Resources_by_rotation::IM::uw::infectious_disease::infectious_disease_zanki, #AK_Step2_v11::#Subjects::Microbiology::01_Bacteria::08_Mycobacteria::Mycobacterium_Tuberculosis::Management, #AK_Step2_v11::Original_decks::Zanki_Step_2::IM::ID
markdown: false

### Text
What is the <i>next step</i> in management for a patient being
treated with <u>RIPE therapy</u> for TB for the past month that
develops <b>mild elevations in AST</b>/<b>ALT</b>?
<div>
  {{c1::Continue with current treatment; monitor LFTs}}
</div>

### Extra
<i>subclinical hepatotoxicity is common within the first few weeks
of isoniazid therapy; it is typically self-limited and resolves
without intervention (significant hepatotoxicity warrants switching
treatment regimens)</i>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/infectious-disease?ref=anki"><img src="_OME_AnkiFlashcards_Topic_4.png"></a>
</div>

### Additional Resources


### One by one

